Loading clinical trials...
Loading clinical trials...
Use of External Nasal Dilator as an Adjuvant to High-Flow Nasal Cannula Oxygen Therapy in Children With Acute Respiratory Failure: A Prospective Randomized Controlled Trial
Conditions
Interventions
External nasal dilator (END)
High flow nasal cannula (HFNC)
Locations
1
United States
LLUCH
Loma Linda, California, United States
Start Date
February 2, 2016
Primary Completion Date
May 19, 2016
Completion Date
June 15, 2016
Last Updated
August 21, 2017
NCT05423301
NCT06750536
NCT06934876
NCT06829732
NCT05681962
NCT04158479
Lead Sponsor
Loma Linda University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions